EarningsQ3 2025 Earnings Report

Rohto Pharmaceutical Co (4527N) Q3 2025 Earnings Report

0 Followers

MX:4527N Q3 2025 EPS Results

Actual EPS$5.61

Consensus EPS$5.26

Beat/MissBeat by +$0.35

One Year Ago EPS$6.21

Actual Revenue$10.59B

Expected Revenue$10.91B

Beat/MissMissed by -$321.49M

YoY Revenue Growth+2.30%

QuarterQ3 2025

Date02/12/2026

TimeTBA

Conference CallThursday, February 12, 2026

MX:4527N Upcoming Earnings

Rohto Pharmaceutical Co's next earnings date is estimated for November 12, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 12, 2026	2026 (Q2)	3.89 / -	3.103	―
Aug 06, 2026	2026 (Q1)	4.75 / 5.62	6.21	-9.50% (-0.59)
May 13, 2026	2025 (Q4)	3.62 / 3.15	3.264	-3.54% (-0.12)
Feb 12, 2026	2025 (Q3)	5.26 / 5.61	6.21	-9.71% (-0.60)
Nov 13, 2025	2025 (Q2)	2.98 / 3.10	2.32	33.76% (+0.78)
Aug 06, 2025	2025 (Q1)	- / 6.21	4.433	40.10% (+1.78)
May 13, 2025	2024 (Q4)	2.98 / 3.26	2.498	30.69% (+0.77)
Feb 12, 2025	2024 (Q3)	5.85 / 6.21	4.998	24.26% (+1.21)
Nov 13, 2024	2024 (Q2)	4.18 / 2.32	3.921	-40.83% (-1.60)
Aug 07, 2024	2024 (Q1)	4.76 / 4.43	4.751	-6.70% (-0.32)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed